Lapland Central Hospital, Lapland Hospital District
Rovaniemi, 96400, Finland
NCT Number: NCT01531049
The purpose of this study is to assess the efficacy and effectiveness of varenicline and nicotine patch combined with motivational interview technique in smoking cessation of young adults over 12 months follow-up.
Looking for future studies?
Notify Me18 year–26 year
All sexes
Interventional
Phase 2 / Phase 3
Rovaniemi, 96400, Finland
Most teenage smokers are still smoking when they become adults confirming that stopping of smoking at young age is difficult although majority of young smokers want to quit. Young smokers experience many relapses partly due to the lack of appropriate and available cessation services. The discomfort experienced during cessation attempts is likely to be negatively associated with cessation success. Quitting of smoking is by the far most important procedure in preventing COPD progression. In Finland, 18-35% of young adults smoke, the variability being associated at least with socioeconomic background, education and geographical area. Our recent studies on male military draftees have shown that smoking is much more frequent in Northern than Southern Finland. However young men want to quit and accept new smoking restrictions. Very few studies are available on quitting attempts or counselling, pharmacotherapy and/or their combinations in young adults who want to quit.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
days 1.-3 0,5mgx1/day, days 4.-7 0,5mgx2/day, day 8 to the 12weeks 1mgx2 /day
Other names: Champix
One patch for 16hours/day and duration of 8 weeks.
Other names: Nicorette
One patch 16hours/day and duration of 8 weeks
Other names: Nicorette
No active medication.O ne patch 16hours and duration for 8 weeks
Other names: Leukomed T
Time frame: 3 months follow-up
Time frame: 3 months follow-up
Time frame: 1, 6 and 12 months follow-up
Tuula Toljamo
Other
Smoking Cessation in Young Adults in Northern Finland
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03206619
Behavior, Habits
Seville, Spain
View Trial DetailsNCT05490251
Behavior, Fractures, Bone
Los Angeles, California, United States
View Trial DetailsNCT04532970
Behavior, Blood-Borne Infections
Gaborone, Botswana
View Trial DetailsNCT04505371
Behavior, Blood-Borne Infections
Seattle, Washington, United States
View Trial Details